Live Breaking News & Updates on Antimicrobial Agents|Page 5

Stay updated with breaking news from Antimicrobial agents. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

No new pathogens in respiratory disease surge, China tells WHO

WHO had asked for more information on ‘undiagnosed pneumonia’ among children in Beijing and the northeastern province of Liaoning. ....

David Hui Shu Cheong , China State Council On , Chinese University Of Hong Kong , Chinese Centre For Disease , Hui Shu Cheong , Chinese University , Hong Kong , Chinese Centre , Disease Control , Antimicrobial Agents , State Council ,

Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update – IT Business Net

Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Ted Jenkins , Satyavrat Sath Shukla , Jonb Bruss , Kevin Winthrop , Ankit Mahadevia , Sath Shukla , Lora Grassilli , Esther Rajavelu , Department Of Health , Government Agency Research , Zeno Group , Exchange Commission , National Institutes Of Health , Human Services , Department Of The Army , Drug Administration , Office Of The , Department Of Defense , Biomedical Advanced Research , Warfighter Medical Research Program Under Award No , Development Authority , Savior Lifetec Corporation , National Institute Of Allergy , Administration For Strategic Preparedness ,

Basilea announces acquisition of fosmanogepix, a phase-3-ready broad-spectrum antifungal

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting. ....

Basel Stadt , Switzerland General , United States , David Veitch , Cresemba Zevtera , Nils Schr , Drug Administration , Amplyx Pharmaceuticals Inc , Swiss Exchange , Head Of Corporate Communications Investor Relations , American Thoracic Society , Basilea Pharmaceutica International Ltd , Basilea Pharmaceutica Ltd , Pfizer Inc , Pharmaceutica Ltd , Amplyx Pharmaceuticals , Chief Executive Officer , Fast Track , Orphan Drug , Qualified Infectious Disease Product , Corporate Communications , Pharmaceutica International Ltd , First In Class Broad Spectrum Agent , Invasive Fungal , Oral Fosmanogepix , First In Class Antifungal Agent ,

Basilea announces acquisition of fosmanogepix, a

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 13, 2023 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a. ....

Basel Stadt , United States , Switzerland General , Nils Schr , Cresemba Zevtera , David Veitch , Drug Administration , Swiss Exchange , Amplyx Pharmaceuticals Inc , American Thoracic Society , Head Of Corporate Communications Investor Relations , Pfizer Inc , Basilea Pharmaceutica Ltd , Basilea Pharmaceutica International Ltd , Pharmaceutica Ltd , Amplyx Pharmaceuticals , Chief Executive Officer , Fast Track , Orphan Drug , Qualified Infectious Disease Product , Corporate Communications , Pharmaceutica International Ltd , First In Class Broad Spectrum Agent , Invasive Fungal , Oral Fosmanogepix , First In Class Antifungal Agent ,

Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update

Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO trial of tebipenem HBr; Trial expected to begin with First Patient, First Visit in 4Q 2023 Conference call and webcast at 4:30pm ET. ....

United States , United Kingdom , Sath Shukla , Lora Grassilli , Keith Rodvold , Kevin Winthrop , Jonb Bruss , Ankit Mahadevia , Ted Jenkins , Esther Rajavelu , Satyavrat Sath Shukla , Department Of The Army , Office Of The , Intravenous Administration To Healthy Adult , Health Media Relations , Warfighter Medical Research Program Under Award No , Administration For Strategic Preparedness , Spero Therapeutics Inc , Department Of Health , Health Affairs , Development Authority , Tebipenem Hbr Research , Drug Administration , Zeno Group , Globenewswire Inc , Exchange Commission ,